Aier Eye Hospital Group Co., Ltd. (SHE:300015)

Market Cap	105.04B
Revenue (ttm)	22.17B
Net Income (ttm)	3.22B
Shares Out	9.30B
EPS (ttm)	0.35
PE Ratio	32.52
Forward PE	25.73
Dividend	0.16 (1.42%)
Ex-Dividend Date	Jun 11, 2025

Volume	46,796,300
Average Volume	51,281,763
Open	11.23
Previous Close	11.23
Day's Range	11.13 - 11.30
52-Week Range	11.13 - 15.89
Beta	0.69
RSI	30.82
Earnings Date	Apr 24, 2026

About Aier Eye Hospital Group

Aier Eye Hospital Group Co., Ltd. operates as a ophthalmology chain medical company in China, Hong Kong, Europe, the United States, and Southeast Asia. The company offers diagnosis and treatment of various ophthalmic diseases, surgical services, medical optometry, and glasses for fundus diseases, refractive correction, glaucoma, corneal diseases, and cataract. It also provides training course for cataract prevention and treatment. Aier Eye Hospital Group Co., Ltd. was founded in 2002 and is headquartered in Changsha, China.

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2002
• Employees: 42,693
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300015

Financial Performance

In 2024, Aier Eye Hospital Group's revenue was 20.98 billion, an increase of 3.02% compared to the previous year's 20.37 billion. Earnings were 3.56 billion, an increase of 5.87%.